CURX News

Latest breaking news and updates for CURX stock.

Track all markets on TradingView

Curanex Pharmaceuticals Inc. Announces Closing of its Initial Public Offering

Jericho, New York, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering ...

How does CURX's valuation and share dilution compare to other early‑stage botanical‑drug companies that have recently gone public? What are the intended uses of the $15 million net proceeds and how will they impact future cash‑burn and milestones? How will the $4.00 IPO price affect CURX's post‑IPO market liquidity and price support?
Finance
about 4 hours ago
Read more globenewswire

Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering

Jericho, New York, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering ...

What is the anticipated post‑IPO share float and dilution, and how might that influence liquidity and short‑term price volatility on the Nasdaq Capital Market? What are the expected use‑of‑proceeds and how will the capital deployment timeline impact Curanex's pipeline milestones and cash runway? How does the $4.00 IPO price and $15 million raise affect CURX's valuation and potential upside compared to similar biotech IPOs?
Ipo
1 day ago
Read more globenewswire